Filing Details
- Accession Number:
- 0001209191-10-033976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-14 13:00:00
- Reporting Period:
- 2010-06-11
- Filing Date:
- 2010-06-14
- Accepted Time:
- 2010-06-14 11:25:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193366 | El Youssef Zein | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-11 | 6,000 | $3.61 | 497,140 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.40 to $3.83. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
